Chinese Journal of Integrative Medicine

, Volume 10, Issue 1, pp 73–77 | Cite as

Study of Traditional Chinese Medicine in intervening vascular remodeling after percutaneous transluminal coronary angioplasty

  • Lu Xiao-yan
  • Xu Hao
  • Shi Da-zhuo
  • Chen Ke-ji


Vascular Remodel Emodin Ligustrazine Tetrandrine Activate Blood Circulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: Have we been aiming at the wrong target? J Am Coll Cardiol 1995;25: 516.PubMedCrossRefGoogle Scholar
  2. 2.
    Waller BF, Pinkerton CA, Orr CM, et al. Restenosis 1to 24 months after clinical successful coronary balloon angioplasty: A necropsy study of 20 patients. J Am Col-loardiol 1991; 17: 58B-70B.CrossRefGoogle Scholar
  3. 3.
    O’Brien ER, Alpens CE, Stewart DK, et al. Hyperpla-sia in primary and restenotic coronary atherectomy tissue implications for antiproliferative therapy. Cir Res 1993;73: 223–231.Google Scholar
  4. 4.
    Mintz GS, Popma JJ, Pichard AD, et al. Arterial re-odeling after coronary angioplasty: A serial intravascu-lar ultrasound study. Circulation 1996;94: 35–43.PubMedGoogle Scholar
  5. 5.
    Gruberg L, Waksman R, Satler LF, et al. Novel ap-proaches for the prevention of restenosis. Expert Opin Investig Drugs 2000;9(11): 2555–2578.PubMedCrossRefGoogle Scholar
  6. 6.
    Faxon DP, Borst C. Remodeling: historical perspectives and definition of terms. Semin Interv Cardiol 1997; 2(3): 145–146.PubMedGoogle Scholar
  7. 7.
    Quarck R, Holvoet P. Restenosis and gene therapy. Expert Opin Biol Ther 2001; 1(1): 79–91.PubMedCrossRefGoogle Scholar
  8. 8.
    Glagov S. Intimai hyperplasia, vascular modeling, and the restenosis problem. Circulation 1994;89: 2888.PubMedGoogle Scholar
  9. 9.
    Lijnen HR. Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 2001; 86(1): 324–333.PubMedGoogle Scholar
  10. 10.
    Pan XM, Wu ZG. Restenosis and vascular remodeling after coronary angioplasty. For Med Cardiovas Dis Fasc 1999;26(2): 78–81.Google Scholar
  11. 11.
    Cai X, Gong LS. Vascular remodeling, tunica adventitia and restenosis after coronary artery intervention. For Med Internal Med Fasc 1999;26(2): 54–57,92.Google Scholar
  12. 12.
    Gong Y, Zhu DL. Mechanisms of tunica adventitia in vascular remodeling. For Med Pathol Clin Med Fasc 1999;19(6): 516–518.Google Scholar
  13. 13.
    Durand E, Mallat Z, Addad F, et al. Time courses of apoptosis and cell hyperplasia and their relationship to arterial remodeling and restenosis after angioplasty in an atherosclerotic rabbit model. J Am Coll Cardiol 2002;39 (10): 1680–1685.PubMedCrossRefGoogle Scholar
  14. 14.
    Hyman KM, Seghezzi G, Pintucci G, et al. Transforming growth factor-beta1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated pro-tein kinase. Surgery 2002; 132(2): 173–179.PubMedCrossRefGoogle Scholar
  15. 15.
    Ibe W, Bartels W, Lindemann S, et al. Involvement of PKC and NF-kappaB in nitric oxide induced apoptosis in human coronary artery smooth muscle cells. Cell Physiol Biochem 2001, 11(5): 231–240.PubMedCrossRefGoogle Scholar
  16. 16.
    Galis ZS, Johnson C, Godin D, et al. Targeted disrup-tion of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial re-modeling. Circ Res 2002; 91(9): 852–859.PubMedCrossRefGoogle Scholar
  17. 17.
    Orbe J, Rodriguez JA, Arias R, et al. Antioxidant vita-mins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: implications for plaque stabilization. Atherosclerosis 2003; 167(1): 45 -53.PubMedCrossRefGoogle Scholar
  18. 18.
    Lu SZ, Chen YD. Diganosing skill and device selection in coronary artery intervention. 1st ed. Beijing: Peoplés Medical Publishing House, 2003: 243–253, 286–293, 294–305.Google Scholar
  19. 19.
    Xu H, Shi DZ, Chen KJ, et al. Clinical study of Xiong-shao capsule on preventing restenosis after coronary in-terventional treatment. Chin J Integr Tradit West Med2000;20(7): 494–497.Google Scholar
  20. 20.
    Shi DZ, Xu FQ, Ma XC, et al. Study of concentrated Xuefu Zhuyu Pill on preventing restenosis in rabbits after percutaneous transluminal coronary angioplasty. J TCM1997;38(11): 685–687.Google Scholar
  21. 21.
    Zhou XM, Lu ZY, Wang DW. Preliminary study of Sal-via miltiorrhiza on preventing experimental coronary restenosis and its mechanism. Chin J Integr Tradit WestMed 1996;16(8): 480–482.Google Scholar
  22. 22.
    Xia H, Li GS, Xu JL, et al. The effect of Notoginseng saponins on rabbits’ c-myc gene expression and SMC pro-liferation after carotid artery endepidermis. Chin J Inter-vent Cardiol 1997;5(1): 45–47.Google Scholar
  23. 23.
    Liu CY, Zhang YH, Guan SM, et al. The effect of pu-erarin to collagen hyperplasia of I after vascular endepi-dermis. Clin J Cardiovasc Dis 1997; 13(3): 176–177.Google Scholar
  24. 24.
    Tang LL, Wang LH, Zhang JH, et al. The effect of Li-gustrazine collagen gene expression of primary passage cultured vascular smooth muscle cell. Chin J Integr Tra-dit West Med 1995;15(11): 666–668.Google Scholar
  25. 25.
    Yan YZ, Chen XY, Wu KJ, et al. The effect of ligus-trazine and 764–3 to procollagen mRNA expression of fi-broblast I and IE. Chin Acad J Med Sci 1996; 18(2): 126–128.Google Scholar
  26. 26.
    Shi ZX, Du JH. Minutes of international conference of “blood-stasis syndrome” general survey and summary of the 4th national “Huoxue Huayu” academic conference. Chin J Integr Tradit West Med 1995; 15 (12): 755 -757.Google Scholar
  27. 27.
    Su JW, Wu WK, Lin SG, et al. Improving effect of Sini decoction to patients’ hemorrheology after PTCA. Chin J Integr Tradit West Med 1997;17(6): 345–347.Google Scholar
  28. 28.
    Xu H, Shi DZ, Chen KJ, et al. Effect of Xiongshao Capsule on vascular remodeling in porcine coronary bal-loon injury model. Chin J Integr Tradit West Med 2001;21(8): 591–594.Google Scholar
  29. 29.
    Xu H, Shi DZ, Chen KJ, et al. Effects of XS0601 on porcine intima apoptosis and relative gene expression of bcl-2 and p53 after coronary artery balloon injury. Chin J Interv Cardiol 2001;9(3): 152–154.Google Scholar
  30. 30.
    Xu H, Shi DZ, Chen KJ, et al. Effect of Xiongshao capsule on SMC proliferation and apoptosis in rabbits’ thoracic aorta by serum pharmacologic method. Chin J Integr Tradit West Med 2000;20(10): 757–760.Google Scholar
  31. 31.
    Liu HB, Wen JK, Han M. Effects of Salvia miltiorrhiza on matrix metalloproteinases and osteopontin gene expression and proliferation of cultured vascular smooth muscle cells. Chin J Integr Tradit West Med 2002; 22 (10): 764–766.Google Scholar
  32. 32.
    Li QP, Lu ZA, Rao MR. Tetrandrine inhibits collagen synthesis of vascular smooth muscle cell. Acta Pharmaceutica Sinica 2001;36(7): 481–484.PubMedGoogle Scholar
  33. 33.
    Li DG, Li JX, Li ZB, et al. Protection of tetrandrine on restenosis after vascualr endepidermis and its molecule mechanism. J Hebei Med Univ 2002;23(2): 68–70.Google Scholar

Copyright information

© The Chinese Journal of Integrated Traditional and Western Medicine Press 2004

Authors and Affiliations

  1. 1.Xiyuan HospitalChina Academy of Traditional Chinese MedicineBeijing

Personalised recommendations